| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.23 | 0.07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |